Topics
Glioblastoma | Treatment | Targeted therapy | Lenvatinib
Home > Publications > Topics > Glioblastoma > Treatment > Targeted therapy > Lenvatinib
Rha
SY, Castanon E, Gill S, Senellart H, Lopez J, Márquez-Rodas
I, Victoria I, Kim TM, Lwin Z, Burger MC, Simonelli M, Cassier PA,
Hendifar AE, Ascierto PA, Dutcus C, Okpara CE, Ghori R, Jin F,
Groisberg R, Villanueva L.
Lenvatinib
plus pembrolizumab for patients with previously treated select
solid tumors: Results from the phase 2 LEAP-005 study recurrent
glioblastoma cohort.
Cancer.
2025 Aug 15;131(16):e70015. doi:
10.1002/cncr.70015. PMID:
40808295. Interventional study. ˍ
ClinicalTrials.gov
ID: NCT03797326.